Evidence map›Paper›PMID 33685078›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2021

[Ten years of research progress in the field of non-viral liver disease].

Q X Wang, X Ma

Open access · greenAbstract read
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Q X WangDepartment of Gastroenterology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Digestive Disease, Shanghai 200001, China.
X MaDepartment of Gastroenterology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Digestive Disease, Shanghai 200001, China.
Renji Hospital · CN

Funding

National Natural Science Foundation of China 82070581, 81770564, 81790634Shanghai Rising-Star Program 18QA1402700
6 · The paper itself

Abstract

The field of non-viral liver disease mainly includes autoimmune liver disease, non-alcoholic fatty liver disease, drug-induced liver injury, genetic metabolic liver disease, and so on. This article emphasis on the key points of clinical and basic research related to the combined field of autoimmune liver disease and non-alcoholic fatty liver disease in past ten years, and review its progress and existing difficulties.

Indexed as

Chemical and Drug Induced Liver InjuryHepatitis, AutoimmuneNon-alcoholic Fatty Liver DiseaseHumansAutoimmune hepatitisAutoimmune liver diseaseGut microbiotaNon-alcoholic fatty liver diseasePrimary biliary cholangitis

Identifiers

PMID33685078
PMCPMC12814650
OpenAlexW3134948777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.